©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Featured Story
Curaleaf’s Aurora Bid Has a Cap, No Floor, and a Contradiction
Curaleaf’s hostile bid asks Aurora Cannabis shareholders to accept an offer advertised at US$4 per share. But the mostly stock consideration has no downside floor, its upside is capped, and U.S. investors would exchange a Nasdaq-listed security for shares traded domestically over the counter. The offer circular also appears to contain outdated information about the conversion of Boris Jordan’s multiple-voting shares.
The Retail Intelligence Gap Holding Cannabis Brands Back
Getting products onto dispensary shelves is not the same as winning at retail. Cannabis brands often lose visibility after distribution, allowing stockouts, poor placement, aging inventory, and margin-draining discounts to go undetected. That gap becomes expensive long before leadership notices it. Retail executives and technology providers explain how store-level scorecards, disciplined field execution, budtender education, and selective distribution can reveal where revenue is leaking.
The Product Experience Begins Before the Package Opens
Before consumers read a label or try what’s inside, they have already begun judging a product’s quality, credibility, and value. Packaging strategist Kary Radestock explains how materials, structure, texture, and opening mechanics create the first product experience and why successful cannabis packaging makes a promise the product can actually keep. The strongest designs don’t merely attract attention on the shelf; they build confidence in the consumer’s hands.
When the Aggressor Becomes the Target
Curaleaf’s proposed hostile takeover places Aurora Cannabis on the receiving end of a playbook it once used successfully. But earlier cannabis takeover battles produced very different endings, and Aurora’s cash-rich balance sheet gives its board room to resist, negotiate, or demand more.
The Cannabis Industry Is Optimizing the Wrong Thing
Cannabis companies devote enormous attention to genetics, potency, and standout harvests. Cultivation veteran Sean Oganesyan argues the more durable competitive advantage is far less glamorous: documented processes, standardized training, disciplined measurement, and operating systems that deliver consistent quality regardless of who is in the room.
Vertical Integration Is an Oversupply Hedge, Not a Margin Play
Vertical integration often is sold as a margin strategy, but its greater value may appear when cannabis supply exceeds demand. Operators that control cultivation and retail gain shelf certainty, direct visibility into customer demand, and a longer planning horizon. Those protections don’t eliminate oversupply risk, but they can help keep a temporary mismatch from becoming a survival crisis.
Study Finds Consumers Are Noticing Cannabis Consolidation, Too
Cannabis operators aren’t alone in worrying about consolidation. Consumers interviewed across nine established adult-use markets praised legalization for improving safety, access, and social acceptance, but many also saw regulatory costs and corporate concentration pushing small businesses aside. Participants also questioned whether cannabis tax revenue has delivered promised community benefits and worry large corporations eventually could shape policy in their favor.
Vireo’s Planet 13 Deal Is about More than Store Count
Vireo Growth’s proposed acquisition of Planet 13 would add 36 dispensaries, a high-profile Las Vegas superstore, and greater density in Florida. But the all-stock deal comes as Planet 13 reports declining revenue, widening losses, and a narrower operating footprint. The assets offer clear strategic value, yet Vireo’s projected scale, including roughly 265 dispensaries across fifteen states, depends on multiple transactions closing and integrating successfully.
How Cannabis Manufacturers Can Fix Throughput Bottlenecks
Cannabis manufacturers often respond to sluggish throughput by investing in faster extraction equipment. But the true constraint may lie in solvent recovery, chilling capacity, facility layout, or operator workflow. Identifying and removing the actual bottleneck can improve cannabinoid recovery, increase production capacity, and provide the operational certainty customers, lenders, and investors expect.
Getting Banked Is Only the Beginning
Cannabis banks continue monitoring deposits, sales, licenses, ownership, and compliance after an account opens. Medical marijuana’s move to Schedule III may add new documentation and reporting questions, especially for businesses serving both medical and adult-use markets. Here, two bankers advise how to strengthen your banking relationship and avoid common pitfalls during the rescheduling transition.















